These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 31127629)
1. Modulation of macrophage subtypes by IRF5 determines osteoclastogenic potential. Yang J; Park OJ; Kim J; Kwon Y; Yun CH; Han SH J Cell Physiol; 2019 Dec; 234(12):23033-23042. PubMed ID: 31127629 [TBL] [Abstract][Full Text] [Related]
2. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Jaguin M; Houlbert N; Fardel O; Lecureur V Cell Immunol; 2013 Jan; 281(1):51-61. PubMed ID: 23454681 [TBL] [Abstract][Full Text] [Related]
3. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression. Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732 [TBL] [Abstract][Full Text] [Related]
4. GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease. Nakano H; Kirino Y; Takeno M; Higashitani K; Nagai H; Yoshimi R; Yamaguchi Y; Kato I; Aoki I; Nakajima H Arthritis Res Ther; 2018 Jun; 20(1):124. PubMed ID: 29895319 [TBL] [Abstract][Full Text] [Related]
5. [Endogenous IFN-β maintains M1 polarization status and inhibits proliferation and invasion of hepatocellular carcinoma cells]. Xie C; Guo B; Liu C; Lin Y; Wu B; Wang Q; Li Z; Tu Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):865-9. PubMed ID: 27363262 [TBL] [Abstract][Full Text] [Related]
6. [Adipose-derived stem cells promote the polarization from M1 macrophages to M2 macrophages]. Yin X; Pang C; Bai L; Zhang Y; Geng L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):332-8. PubMed ID: 26927552 [TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts. Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739 [TBL] [Abstract][Full Text] [Related]
8. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling. Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799 [TBL] [Abstract][Full Text] [Related]
9. [Interferon regulatory factor 5(IRF5) regulates the differentiation of bone marrow-derived macrophages in mice]. Sun K; Qu J; Chen J; Dang S; He S; Zhang J; Xie R; Wang Y; Zhang J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):168-73. PubMed ID: 29762983 [TBL] [Abstract][Full Text] [Related]
10. Neonatal Osteomacs and Bone Marrow Macrophages Differ in Phenotypic Marker Expression and Function. Mohamad SF; Gunawan A; Blosser R; Childress P; Aguilar-Perez A; Ghosh J; Hong JM; Liu J; Kanagasabapathy D; Kacena MA; Srour EF; Bruzzaniti A J Bone Miner Res; 2021 Aug; 36(8):1580-1593. PubMed ID: 33900648 [TBL] [Abstract][Full Text] [Related]
11. Allostimulatory activity as a criterion of the functional phenotype of human macrophages. Yankovskaya AA; Shevela EY; Sakhno LV; Tikhonova MA; Dome AS; Ostanin AA; Chernykh ER Hum Immunol; 2019 Oct; 80(10):890-896. PubMed ID: 31447056 [TBL] [Abstract][Full Text] [Related]
12. IRF5 is a specific marker of inflammatory macrophages in vivo. Weiss M; Blazek K; Byrne AJ; Perocheau DP; Udalova IA Mediators Inflamm; 2013; 2013():245804. PubMed ID: 24453413 [TBL] [Abstract][Full Text] [Related]
13. M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone. De Vries TJ; Schoenmaker T; Aerts D; Grevers LC; Souza PP; Nazmi K; van de Wiel M; Ylstra B; Lent PL; Leenen PJ; Everts V J Cell Physiol; 2015 Jan; 230(1):210-25. PubMed ID: 24962140 [TBL] [Abstract][Full Text] [Related]
15. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts. Kim MH; Ryu SY; Choi JS; Min YK; Kim SH J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230 [TBL] [Abstract][Full Text] [Related]
16. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically. Valverde P; Tu Q; Chen J J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB. Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671 [TBL] [Abstract][Full Text] [Related]
18. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189 [TBL] [Abstract][Full Text] [Related]
19. Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. Ambarus CA; Krausz S; van Eijk M; Hamann J; Radstake TR; Reedquist KA; Tak PP; Baeten DL J Immunol Methods; 2012 Jan; 375(1-2):196-206. PubMed ID: 22075274 [TBL] [Abstract][Full Text] [Related]
20. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]